Publications

Publications 2018

December 31, 2018
  1. Pongpirul W, Pongpirul K, Ananworanich J, Klinbuayaem V, Avihingsanon A, Prasithsirikul W. Chronic kidney disease incidence and survival of Thai HIV-infected patients. AIDS. 2018 Jan 28;32(3):393-398. doi: 10.1097/QAD.0000000000001698.
  2. Puthanakit T, Wittawatmongkol O, Poomlek V, Sudjaritruk T, Brukesawan C, Bunupuradah T, Sricharoenchai S, Chuanjaroen T, Prasitsuebsai W, Chokephaibulkit K. Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density. J Virus Erad. 2018 Jan 1;4(1):6-11.
  3. Do TC, Kerr SJ, Avihingsanon A, Suksawek S, Klungkang S, Channgam T, Odermatt CC, Maek-A-Nantawat W, Ruxtungtham K, Ananworanich J, Valcour V, Reiss P, Wit FW. HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART. J Virus Erad. 2018 Jan 1;4(1):41-47.
  4. Bunupuradah T, Phupitakphol T, Sophonphan J, Prasitsuebsai W, Anugulruengkitt S, Jantarabenjakul W, Sopa B, Ruxrungtham K, Chanakul A, Puthanakit T; HIV-NAT 015 Study Team. Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents. Pediatr Infect Dis J. 2018 Jan;37(1):66-70. doi: 10.1097/INF.0000000000001684.
  5. Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S; MARCH study group. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. HIV Med. 2018 Jan;19(1):65-71. doi: 10.1111/hiv.12532. Epub 2017 Jul 13.
  6. Jiamsakul A, Lee M, Nguyen KV, Merati TP, Cuong DD, Ditangco R, Yunihastuti E, Kamarulzaman A, Zhang F, Kiertiburanakul S, AvihingasanonA, Ng OT, Sim BLH, Wong W, Ross J, Law M. Socio-economic Statuses and Risk of Tuberculosis – A Case-Control Study of HIV-infected Patients in Asia. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):179-186. doi: 10.5588/ijtld.17.0348.
  7. Smolders EJ, Thammajaruk N, de Kanter CTMM, Colbers A, Chaiyahong P, Cuprasitrut T, Chittmittraprap S, Apornpong T, Khemnark S, Tangkijvanich P, Burger DM, Avihingsanon A. Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics. Trop Med Int Health. 2018 Mar;23(3):295-305. doi: 10.1111/tmi.13027. Epub 2018 Jan 10.
  8. Paul R, Apornpong T, Prasitsuebsai W, Puthanakit T, Saphonn V, Aurpibul L, Kosalaraksa P, Kanjanavanit S, Luesomboon W, Ngampiyaskul C, Suwanlerk T, Chettra K, Shearer WT, Valcour V, Ananworanich J, Kerr S. Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV. J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):417-426. doi: 10.1097/QAI.0000000000001619.
  9. Henderson GE, Peay HL, Kroon E, Cadigan RJ, Meagher K, Jupimai T, Gilbertson A, Fisher J, Ormsby NQ, Chomchey N, Phanuphak N, Ananworanich J, Rennie S. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. J Med Ethics. 2018 Apr;44(4):270-276. doi: 10.1136/medethics-2017-104433. Epub 2017 Nov 10.
  10. Puthanakit T, Thepnarong N, Chaithongwongwatthana S, Anugulruengkitt S, Anunsittichai O, Theerawit T, Ubolyam S, Pancharoen C, Phanuphak P. Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission. J Virus Erad. 2018 Apr 1;4(2):61-65.
  11. Jiamsakul A, Yunihastuti E, Van Nguyen K, Merati TP, Do CD, Ditangco R, Ponnampalavanar S, Zhang F, Kiertiburanakul S, Lee MP, Avihingasanon A, Ng OT, Sim BL, Wong W, Ross J, Law M. Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia. HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12621. [Epub ahead of print]
  12. Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL, Poehlman-Roediger M, Vjecha MJ, Penalva de Oliveira AC, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A, Mueller NJ, Winston A, Nsubuga MS, Lal L, Price RW; INSIGHT START Neurology Substudy Group. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. AIDS. 2018 May 15;32(8):985-997. doi: 10.1097/QAD.0000000000001778.
  13. Prasitsuebsai W, Sethaputra C, Lumbiganon P, Hansudewechakul R, Chokephaibulkit K, Truong KH, Nguyen LV, Mohd Razali KA, Nik Yusoff NK, Fong MS, Teeraananchai S, Ananworanich J, Durier N; TApHOD ACASI study group of IeDEA Asia-Pacific. Adherence to antiretroviral therapy, stigma and behavioral risk factors in HIV-infected adolescents in Asia. AIDS Care. 2018 Jun;30(6):727-733. doi: 10.1080/09540121.2018.1425363. Epub 2018 Jan 16.
  14. Hodder S, Squires K, Kityo C, Hagins D, Avihingsanon A, Kido A, Jiang S, Kulkarni R, Cheng A, Cao H. Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):209-213. doi: 10.1097/QAI.0000000000001663.
  15. Kippax S, Mayer KH, Sohn A, Bekker LG, Pozniak A, Beyrer C, Lewin SR, Ryan O, Phanuphak P, Kirby M. In memoriam: Professor David Cooper (1949 to 2018). J Int AIDS Soc. 2018 Jun;21(6):e25152. doi: 10.1002/jia2.25152.
  16. Colby DJ, Trautmann L, Pinyakorn S, Leyre L, Pagliuzza A, Kroon E, Rolland M, Takata H, Buranapraditkun S, Intasan J, Chomchey N, Muir R, Haddad EK, Tovanabutra S, Ubolyam S, Bolton DL, Fullmer BA, Gorelick RJ, Fox L, Crowell TA, Trichavaroj R, O’Connell R, Chomont N, Kim JH, Michael NL, Robb ML, Phanuphak N, Ananworanich J; RV411 study group. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat Med. 2018 Jul;24(7):923-926. doi: 10.1038/s41591-018-0026-6. Epub 2018 Jun 11.
  17. Colby DJ, Posuwan N, Kroon E, Phanuphak N, Ananworanich J, Robb ML, Phanuphak P, Poovorawan Y; SEARCH010/RV254 Study Team. Reply to Chen et al. J Infect Dis. 2018 Jul 2;218(3):505-507. doi: 10.1093/infdis/jiy161.
  18. Paul R, Prasitsuebsai W, Jahanshad N, Puthanakit T, Thompson P, Aurpibul L, Hansudewechakul R, Kosalaraksa P, Kanjanavanit S, Ngampiyaskul C, Luesomboon W, Lerdlum S, Pothisri M, Visrutaratna P, Valcour V, Nir TM, Saremi A, Kerr S, Ananworanich J; Pediatric Randomized Early versus Deferred Initiation in Cambodia and Thailand (PREDICT) Study Group. Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV. Pediatr Infect Dis J. 2018 Jul;37(7):662-668. doi: 10.1097/INF.0000000000001852.
  19. Simonsen L, Higgs E, Taylor RJ, Wentworth D, Cozzi-Lepri A, Pett S, Dwyer DE, Davey R, Lynfield R, Losso M, Morales K, Glesby MJ, Weckx J, Carey D, Lane C, Lundgren J; INSIGHT FLU002 and FLU003 Study Groups. Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic. Clin Infect Dis. 2018 Jul 18;67(3):341-349. doi: 10.1093/cid/ciy088.
  20. Sohn AH, Kerr SJ, Hansudewechakul R, Gatechompol S, Chokephaibulkit K, Dang HLD, Tran DNH, Achalapong J, Teeratakulpisarn N, Chalermchockcharoenkit A, Thamkhantho M, Pankam T, Singtoroj T, Termrungruanglert W, Chaithongwongwatthana S, Phanuphak N; HPV in Adolescents Study. Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth. Clin Infect Dis. 2018 Aug 1;67(4):606-613. doi: 10.1093/cid/ciy144.
  21. Aurpibul L, Kariminia A, Vibol U, Fong MS, Le ON, Hansudewechakul R, Bunupuradah T, Kurniati N, Chokephaibulkit K, Kumarasamy N, Wati DK, Yusoff NKN, Razali KAM, Nallusamy RA, Sohn AH, Lumbiganon P; TREAT Asia Pediatric HIV Observational Database (TApHOD) of IeDEA Asia-Pacific. Seroprevalence of Hepatitis B among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database. Pediatr Infect Dis J. 2018 Aug;37(8):788-793. doi: 10.1097/INF.0000000000001901.
  22. Kiatbumrung R, Chuaypen N, Payungporn S, Avihingsanon A, Tangkijvanich P. The Association of PNPLA3, COX-2 and DHCR7 Polymorphisms with Advanced Liver Fibrosis in Patients with HCV Mono- Infection and HCV/HIV Co-Infection. Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2191-2197.
  23. Han WM, Apornpong T, Kerr SJ, Hiransuthikul A, Gatechompol S, Do T, Ruxrungtham K, Avihingsanon A. CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.AIDS Res Ther. 2018 Sep 27;15(1):13. doi: 10.1186/s12981-018-0200-4.
  24. Hoy JF, Richardson R, Ebeling PR, Rojas J, Pocock N, Kerr SJ, Martinez E, Carr A for the ZEST Study Investigators. Zoledronic acid is superior to tenofovir DF-switching for low bone mineral density in adults with HIV, a randomised trial. AIDS. 2018 Sep 10;32(14):1967-1975. doi: 10.1097/QAD.0000000000001911.
  25. Kancheva Landolt N, Chaithongwongwatthana S, Nilgate S, Teeratakulpisarn N, Ubolyam S, Apornpong T, Ananworanich J, Phanuphak N; HIVNAT 199 study team. Use of copper intrauterine device is not associated with higher bacterial vaginosis prevalence in Thai HIV-positive women. AIDS Care. 2018 Nov;30(11):1351-1355. doi: 10.1080/09540121.2018.1450479. Epub 2018 Mar 15.
  26. Jiamsakul A, Kerr SJ,  Kiertiburanakul S, Azwa I, Zhang F Chaiwarith R, Wong W, Ly PS, Kumarasamy N, Ditangco R, Pujari S, Yunihastuti E, Do CD, Merati TP, Nguyen KV, Lee MP, Choi JY, Oka S, Kantipong P, Sim BLH, Ng OT, Ross J, Law M. Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia. AIDS Care. 2018 Dec;30(12):1560-1566. doi: 10.1080/09540121.2018.1499859. Epub 2018 Jul 18.
  27. Han WM, Ohata PJ, Nanthapisal K, Ruengpanyathip C, Sattayamong P, Avihingsanon A, Puthanakit T, Gatechompol S, Hiransuthikul A, Kerr SJ, Ramautarsing R, Ubolyam S, Kroon E, Colby D, Sacdalan C, Seekaew P, Phanuphak N, Ruxrungtham K & Phanuphak P; on behalf of the Symposium Team. HIV medicine as double-sided sword: care and prevention. Future Virology. 2018; https://doi.org/10.2217/fvl-2018-0017.
  28. Teeraananchai S, Kerr SJ, Ruxrungtham K, Avihingsanon A, Chaivooth S, Teeraratkul A, Bhakeecheep S, Ongwandee S, Thanprasertsuk S, Law MG. Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand. Antivir Ther. 2018;23(6):529-538. doi: 10.3851/IMP3233.
  29. Yao AH, Moore CL, Lim PL, Molina JM, Madero JS, Kerr S, Mallon PW, Emery S, Cooper DA, Boyd MA & the Second-Line Study Group. Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.
    Antivir Ther. 2018;23(1):21-32. doi: 10.3851/IMP3171.
  30. Hiransuthikul A, Thammajaruk N, Techatanawat I, Karachot B, Chuasuwan B, Manamuti C, Duereh M, Sawpitiporn M, Sophonphan J, Gatechompol S, Avihingsanon A, Bowonwattanuwong C, Ruxrungtham K; HIV-NAT 223 study team. Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults. Antivir Ther. 2018;23(8):699-703. doi: 10.3851/IMP3267.
  31. Jantarabenjakul W, Anugulruengkitt S, Kasipong N, Thammajaruk N, Sophonphan J, Bunupuradah T, Cressey TR, Colbers A, Burger DM, Phongsamart W, Puthanakit T, Pancharoen C; HIVNAT 220 study. Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents. Antivir Ther. 2018;23(3):259-265. doi: 10.3851/IMP3198.